Literature DB >> 7813112

Technical report: results of immunological tests on faecal extracts are likely to be extremely misleading.

A Ferguson1, K A Humphreys, N M Croft.   

Abstract

Clinical investigation of gut immunity is difficult because of the need to study intestinal tissues or secretions directly. Others have reported that immunoglobulins, antibodies and cytokines can be detected in saline extracts of faeces. We have assessed the validity of this approach by measuring immunoglobulins, albumin, alpha 1-antitrypsin and isotype-specific antibodies in matched samples of faeces and whole gut lavage fluid. Results were compared as estimated output per day, and by using haemoglobin as a common reference substance. Samples were obtained from 10 patients with active inflammatory bowel disease and 10 with other benign GI diseases. For immunoglobulins, albumin and antibodies, the amount detected in faeces varied from < 0.01% to 35.5% (based on estimated daily output) and < 0.01% to 18.5% (based on haemoglobin) of the amount known to be produced in the gut from results of assays on whole gut lavage fluid (WGLF); there were significantly higher rates of recovery in faecal specimens from patients with active gut inflammation than from other patients. Detection rates and titres of specific antibody in faeces were even lower than those for immunoreactive IgA. These data indicate that immunological tests on saline extracts of faeces do not represent the true status of the gut humoral immune system, and such studies should be strongly discouraged.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7813112      PMCID: PMC1534154          DOI: 10.1111/j.1365-2249.1995.tb03474.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Evaluation of intestinal clearance and faecal excretion of alpha 1-antiproteinase and immunoglobulins during Crohn's disease and ulcerative colitis.

Authors:  N Kapel; D Meillet; L Favennec; D Magne; D Raichvarg; J G Gobert
Journal:  Eur J Clin Chem Clin Biochem       Date:  1992-04

2.  Secretory IgA in protein-calorie malnutrition.

Authors:  V Reddy; N Raghuramulu; C Bhaskaram
Journal:  Arch Dis Child       Date:  1976-11       Impact factor: 3.791

3.  Measurement of immunoglobulin A, G, and M class rotavirus antibodies in serum and mucosal secretions.

Authors:  B McLean; S Sonza; I H Holmes
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

4.  Use of whole-gut lavage to measure intestinal immunity in healthy Sierra Leonean children.

Authors:  M Hodges; K Kingstone; W G Brydon; J Sallam; A Ferguson
Journal:  J Pediatr Gastroenterol Nutr       Date:  1994-07       Impact factor: 2.839

5.  Serum and small intestinal immunoglobulin levels in undernourished children.

Authors:  R G Bell; K J Turner; M Gracey
Journal:  Am J Clin Nutr       Date:  1976-04       Impact factor: 7.045

6.  Coproantibodies in hepatitis A: detection by enzyme-linked immunosorbent assay and immune electron microscopy.

Authors:  S A Locarnini; A G Coulepis; J Kaldor; I D Gust
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

7.  IgE levels in faecal extracts of patients with food allergy.

Authors:  K Sasai; S Furukawa; T Sugawara; K Kaneko; M Baba; K Yabuta
Journal:  Allergy       Date:  1992-12       Impact factor: 13.146

8.  Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection.

Authors:  D G de Silva; L N Mendis; N Sheron; G J Alexander; D C Candy; H Chart; B Rowe
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

9.  Tumour necrosis factor alpha in stool as a marker of intestinal inflammation.

Authors:  C P Braegger; S Nicholls; S H Murch; S Stephens; T T MacDonald
Journal:  Lancet       Date:  1992-01-11       Impact factor: 79.321

10.  Immunoglobulins and other serum proteins in feces from infants and children.

Authors:  B Haneberg; O Tonder
Journal:  Scand J Immunol       Date:  1973       Impact factor: 3.487

View more
  21 in total

1.  Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.

Authors:  D Externest; B Meckelein; M A Schmidt; A Frey
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.

Authors:  F Qadri; G Jonson; Y A Begum; C Wennerås; M J Albert; M A Salam; A M Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

3.  Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease.

Authors:  R Troncone; N Caputo; A Campanozzi; M Cucciardi; V Esposito; R Russo; B De Vizia; L Greco; S Cucchiara
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 4.  Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cells.

Authors:  Bruno Guy
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

5.  Measurement of immunoglobulin concentrations in the feces of healthy dogs.

Authors:  I R Peters; E L Calvert; E J Hall; M J Day
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

6.  Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls.

Authors:  S C Bischoff; J Grabowsky; M P Manns
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

7.  Purification and functional characterization of mucosal IgA from vaccinated and SIV-infected rhesus macaques.

Authors:  Thomas Musich; Thorsten Demberg; Ian L Morgan; Jacob D Estes; Genoveffa Franchini; Marjorie Robert-Guroff
Journal:  Clin Immunol       Date:  2015-04-01       Impact factor: 3.969

8.  Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.

Authors:  M W Russell; Z Moldoveanu; P L White; G J Sibert; J Mestecky; M Michalek S
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees.

Authors:  C Wennerås; F Qadri; P K Bardhan; R B Sack; A M Svennerholm
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 10.  Rectal effluent as a research tool.

Authors:  Jana M Rocker; Jack A DiPalma; Lewis K Pannell
Journal:  Dig Dis Sci       Date:  2014-09-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.